CELSENTRI

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug CELSENTRI contains one active pharmaceutical ingredient (API):

1 Maraviroc UNII MD6P741W8A - MARAVIROC

Maraviroc is a member of a therapeutic class called CCR5 antagonists. Maraviroc selectively binds to the human chemokine receptor CCR5, preventing CCR5-tropic HIV-1 from entering cells. Read about Maraviroc

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CELSENTRI Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AX09	Maraviroc	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AX Other antivirals
Discover more medicines within J05AX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10318C, 10355B
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510612403113312, 510612406112317, 510612410111311, 510612414115311
Country: CA	Health Products and Food Branch	Identifier(s): 02299844, 02299852
Country: EE	Ravimiamet	Identifier(s): 1347274, 1347285, 1347296, 1347308, 1347319, 1347320, 1347331, 1347342, 1750508, 1750519, 1750520
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 07418003, 07418008
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 061092, 166487
Country: FR	Base de données publique des médicaments	Identifier(s): 60992262, 61182724, 62094362, 64933044, 65936214
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 126610, 126613, 348834, 348849, 348852
Country: HK	Department of Health Drug Office	Identifier(s): 56786, 56798
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6279, 6280
Country: JP	医薬品医療機器総合機構	Identifier(s): 6250034F1025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1028289, 1028290, 1028291, 1028292, 1028293, 1028294, 1028295, 1028296, 1028297, 1028298, 1083705, 1083706, 1083707
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 149942, 149950, 85413, 85421
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100180170, 100180186, 100387125, 100387154, 100387160
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64977001, W64977002, W64977003, W64977004, W64977005, W64978001, W64978002, W64978003, W64978004, W64978005, W64979001, W64980001, W64981001
Country: SG	Health Sciences Authority	Identifier(s): 13640P, 13641P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522094493, 8699522094509, 8699522094516, 8699522094523, 8699522094547, 8699522094554, 8699522094585, 8699522094592
Country: ZA	Health Products Regulatory Authority	Identifier(s): 42/20.2.8/0941, 42/20.2.8/0942